Tennessee Oncology/Sarah Cannon Research Institute — Nashville, Tennessee

Tennessee Oncology/Sarah Cannon Research Institute is a clinical research site located in Nashville, Tennessee, United States 37201.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

Tennessee Oncology/Sarah Cannon Research Institute has participated in 24 clinical trials with 3 currently active.

Therapeutic areas: Cancer, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms.

Sponsors: Scholar Rock, Inc., Astellas Pharma Global Development, Inc., Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology/Sarah Cannon Research Institute?

Tennessee Oncology/Sarah Cannon Research Institute has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology/Sarah Cannon Research Institute conducted?

Tennessee Oncology/Sarah Cannon Research Institute has 24 clinical trials on record, with 3 currently active. Their work covers Cancer, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms.

Is Tennessee Oncology/Sarah Cannon Research Institute accredited by Crixeo Clinical Trials?

Tennessee Oncology/Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology/Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.